abstract |
The present invention provides the use of such compounds, in particular TGF, in which the inhibition, regulation and / or modulation of signal transduction by ATP consuming proteins such as [1,8] naphthyridine derivatives and kinases of the following formula (I) plays a role Inhibitors of -beta receptor kinases and the use of such compounds for the treatment of kinase-induced diseases, in particular for the treatment of tumors. |